Best Nanotechnology Companies in New York, United States
The 52 best Nanotechnology companies in New York, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Nanotronics.
Our analysis of 50 Nanotechnology companies
$6.5b in tracked funding; 78% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Nanotechnology companies in New York
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Nanotronics Provider of an automated vision-based inspection system | $136M | 50 mo ago | 94 | Matthew Putman Founder & CEO | Series E | 5 patents Computational imaging and affinity-driven self-assembly of photonic/electronic devices. | — |
| 2 | Cresilon Developer of hemostatic products for wound care 60Funding top 22%Growth top 32%Moat top 32%Product top 35% All 10 signals ▾Fundingtop 22% Growthtop 32% Moattop 32% Producttop 35% Techtop 37% Patentstop 42% Innovationtop 48% Marketbottom 46% Globalbottom 36% Newsbottom 18% Funding: Raised $81.7M across 8 rounds · 8 rounds over 10 yrs (0.8/yr) Growth: Headcount 53 → 73 (+38%) across vintages · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $82M | 3 mo ago | 73 | — | Series B | 40 patents Surgical hemostatic adhesive polymers and in‑situ cross‑linkable wound‑sealant scaffolds. | — |
| 3 | Panacela Labs Development and commercialization of drugs for the treatment of oncology or other diseases. | $40M | 127 mo ago | 1 | Yakov Kogan CEO | Deadpooled | 32 patents Immuno‑oncology therapeutics: TLR agonist gene vectors and Myc‑targeting small molecules. | — |
| 4 | Therapyxinc Innovating microparticulate immune therapeutics for cancer, infectious disease, and inflammatory disorders 14Innovation top 43%Funding top 44%Product bottom 44%Global bottom 32% All 6 signals ▾Innovationtop 43% Fundingtop 44% Productbottom 44% Globalbottom 32% Techbottom 25% Marketbottom 19% Innovation: 2 product lines Funding: Raised $17.7M across 5 rounds · 5 rounds over 18 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 14/100 | $18M | 15 mo ago | 11 | — | Funding Raised | — | — |
| 5 | Intrinsiq Materials Nanomaterials innovator creating advanced electronic inks and pastes for printed electronics | $17M | 118 mo ago | 26 | — | Series A | — | — |
| 6 | Coferon News, business, technology, automotive, and lifestyle content provider | $16M | 131 mo ago | — | Colin Goddard Chairman and CEO | Deadpooled | 33 patents Multimerizable small‑molecule ligands for protein‑targeted therapeutic and diagnostic agents | — |
| 7 | Nanoprobes Nanoparticle technology for imaging, microscopy, and biodetection solutions | $13M | 121 mo ago | 8 | James Hainfeld Founder & CEO | Funding Raised | 34 patents Patents concentrated in chemistry & materials | — |
| 8 | AiTA Bio Developer of drug delivery devices to treat multiple diseases | $8M | 50 mo ago | — | Dilan Casanovas Co-Founder | Series A | — | — |
| 9 | Primet Precision Advanced materials company manufacturing battery components | $8M | 162 mo ago | 14 | Larry Thomas ex-CEO | Series B | — | — |
| 10 | SIMPore Nanomembrane technology for life science, material science, and microplastic analysis | $7M | 18 mo ago | 11 | Paul Then Chief Executive Officer | Funding Raised | 35 patents Patents concentrated in health & consumer products | 3 launchs · 1 partnership |
| 11 | NanoMas Technologies Provider of research and development services for nanotechnology | $3M | 212 mo ago | — | — | Deadpooled | 22 patents Patents concentrated in chemistry & materials | — |
| 12 | Millennial Scientific Manufacturer of advanced materials for chromatography | $3M | 43 mo ago | 7 | Balaji Sitharaman Founder & President | Funding Raised | — | 1 launch |
| 13 | BioSapien Developer of 3D-printed drug delivery platforms for targeted pharmaceutical agents | $2M | 12 mo ago | 2 | Khatija Ali Founder and CEO | Seed | 34 patents Controlled drug‑release surgical implants for localized therapy and wound healing | — |
| 14 | SensoDx Programmable bio-nano-chip for protein, drug, oligonucleotide, cell counting and cytology assays | $2M | 81 mo ago | — | John T. McDevitt Founder & Chief Science Officer | Deadpooled | — | — |
| 15 | Nanowear Wearable garment based on nanosensor technology for medical monitoring | $2M | 106 mo ago | 22 | — | Seed | 34 patents Integrated nanosensor textiles for continuous cardiac, pulmonary, neurological and wound monitoring | — |
| 16 | ThermoAura Develops and manufactures nanomaterials for energy conversion applications | $1M | 123 mo ago | — | Rutvik Mehta Co-Founder & CEO | Deadpooled | 4 patents Patents concentrated in electrical & electronics | — |
| 17 | Cerion Nanomaterials Manufacturer of custom metal, metal oxide, and ceramic nanomaterials | $1M | 228 mo ago | 29 | — | Series A | — | — |
| 18 | Xallent Designer and manufacturer of advanced nano probing solutions | $942K | 126 mo ago | 6 | — | Funding Raised | 49 patents Precision probe and optical testing instrumentation for semiconductor and optoelectronic devices | — |
| 19 | New Scale Technologies Developer of closed-loop positioning solutions | $784K | 125 mo ago | 25 25 → 31 (+24%) | — | Seed | 51 patents Precision electromechanical actuation for optical beam steering and haptic feedback systems | 3 launchs |
| 20 | Manhattan Scientifics Technology developer company focused on commercialization of technologies in the nano-medicine space | $407K | 139 mo ago | 1 | — | Public | 20 patents Nanostructured titanium and high‑shear aluminum alloy processing for high‑strength, conductive components | — |
| 21 | Besstech Innovating anode technology for high-performance, long-lasting, and fast-charging lithium-ion batteries | $250K | 134 mo ago | 4 | Fernando Gomez Baquero Co-Founder & CEO | Seed | — | — |
| 22 | Graphene Devices Manufactures Graphene and Graphene-based dispersions & coatings | $225K | 141 mo ago | — | Rob Anstey CEO | Deadpooled | — | — |
| 23 | ChromaNanoTech Developer of light-absorbing additives for anti-corrosion, labeling, and 3D printing | $150K | 126 mo ago | 2 | Wayne Jones Co-Founder | Funding Raised | — | — |
| 24 | TargaGenix Developer of nanoemulsion chemotherapeutics for drug-resistant tumors & cancer stem cells | $100K | 94 mo ago | — | James Egan CEO & President | Deadpooled | 20 patents Targeted nanoemulsion delivery of taxoid chemotherapeutics, often combined with immunotherapy | — |
Top 12 Nanotechnology companies in New York
#1
Series B · New York City, New York · founded 2010 · 73 employees$81.7Mraised▾
Developer of hemostatic products for wound care. The company offers VETIGEL Hemostatic Gel(a prescription hemostatic gel kit for animal use only. It can stop moderate to severe bleeds in animals), and TRAUMAGEL a hemostatic device for temporary use to control external traumatic bleeding not amenable to tourniquet application.
- Apr 2026Series B$5M
- Nov 2025Series B$6.7M
- Apr 2024Series B$25M
- Aug 2023Series A$17.2M
#2
Funding Raised · Buffalo, New York · founded 2001 · 11 employees$17.7Mraised▾
Innovating microparticulate immune therapeutics for cancer, infectious disease, and inflammatory disorders. This biotechnology company is focused on discovering and developing advanced therapies using its unique technology for sustained-release microparticulate protein therapeutics. These biologics are formulated for parenteral, oral, and mucosal delivery. The company aggressively protects its innovations through patent filings. It is developing both therapeutic and prophylactic vaccines. The company is dedicated to changing the future of pharmaceuticals by addressing critical unmet needs in cancer, infectious diseases, and inflammatory disorders. This involves research and development of first-in-class immune therapies.
- Apr 2025Grant (prize money)$5.2M
- Jun 2013Grant (prize money)$6M
- Mar 2011Grant (prize money)—
- Mar 2011Grant (prize money)$6M
#3
Funding Raised · West Henrietta, New York · founded 2007 · 11 employees$6.7Mraised▾
Nanomembrane technology for life science, material science, and microplastic analysis. They develop and manufacture silicon nanomembranes and BioMEMS technologies. Their products include porous membrane chips, TEM grids, X-Ray windows, and particle filters. These products enable superior data generation and analysis in transmission electron microscopy, X-ray microscopy, particle analysis, cell culture, nanofiltration, and microplastic analysis. They offer custom fabrication services to meet unique application needs. The company is ISO certified, demonstrating a commitment to quality. They serve researchers in life sciences and materials science, providing tools for nanoscale specimen analysis. They are a bioMEMS company advancing research and innovation in healthcare and beyond. They offer resources like publications, application notes, and technical data sheets. They are a nanotechnology company in the USA.
- Jan 2025Grant (prize money)$1.4M
- May 2020Grant (prize money)$1.9M
- Sep 2019Grant (prize money)$1.4M
- Mar 2018Grant (prize money)$225K
#4
Seed · New York City, New York · founded 2018 · 2 employees$1.8Mraised▾
Developer of 3D-printed drug delivery platforms for targeted pharmaceutical agents. The company focuses on creating minimally invasive methods for delivering medication directly. It utilizes its technology to provide drugs locally, avoiding negative systemic effects. The company's patented technology aims to transform patient care through innovative therapies.
- Jul 2025Seed$1.8M
- Jan 2025Seed$1.5M
- Dec 2024Seed$5.5M
- Dec 2021Seed$1.8M
#5
Series E · Brooklyn, New York · founded 2009 · 94 employees$136.3Mraised▾
Developer of robotic industrial microscopic devices designed to improve industrial image inspection and analysis. The company's ML and AI-based devices leverage optical microscopy, 3D imaging, and computational super-resolution and offer automatic wafer handling, rapid scanning, defect reports, and wafer mosaicing, enabling aerospace, electronics, and pharmaceutical industries to accelerate the inspection of wafers and images while eliminating illusions.
#6
Deadpooled · New York City, New York · founded 2011 · 1 employees$39.9Mraised▾
Panacela Labs is into development and commercialization of drugs for the treatment of oncology or other diseases. The Company’s lead development program is Mobilan, a nanoparticle-formulated, recombinant non-replicating adenovirus in clinical development as a universal cancer therapy. This is a joint venture company founded in 2011 by Cleveland BioLabs a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation.
- Dec 2015Series A$2.9M
- Oct 2011Series A$37M
#7
Series A · New York · founded 2020$8.5Mraised▾
Developer of drug delivery devices to treat multiple diseases. The company is developing Micro-Electro-Mechanical Systems (MEMS) augmented biology platform a microscopic device that is integrated with nanoscale to provide precision dosing for the treatment of autoimmune disorders, aggressive cancers, addiction, and pain management.
- May 2022Series A$8.5M
#8
Series A · Rochester, New York · founded 2007 · 26 employees$17.1Mraised▾
Nanomaterials innovator creating advanced electronic inks and pastes for printed electronics. The company develops customized, air-handleable electronic inks and pastes as a greener, lower-cost alternative to conventional electronic printing materials. Utilizing a unique manufacturing process, their nanomaterial-based ink is highly functional and can be deposited via commercially available inkjet and screen printers in a room-temperature environment. Sintering can be achieved using commercial broadband flash systems or laser systems. They focus on stable nano metal powders and ink formulations, overcoming the inherent instability of Cu nano particles. Their materials are readily dispersed in solvents and resins. They develop NiSi Contacts for PVAirhandleable, printable NiSi suited for printing on ARC layers in Si solar cells, Copper for Underfills and Packaging for thermal management, and Doped Silicon Ink for Logic Applications with demonstrated mobilities equal to that of amorphous silicon.
- Aug 2016Series A$3M
- Mar 2015Grant (prize money)$1.1M
- Jan 2015Grant (prize money)$2M
- Oct 2014Grant (prize money)$450K
#9
Deadpooled · Stony Brook, New York · founded 2009$15.6Mraised▾
News, business, technology, automotive, and lifestyle content provider It delivers trending news, business insights, technology updates, automotive reviews, and lifestyle articles. The platform utilizes digital marketing strategies, including buzzer marketing, to enhance brand awareness and engagement. It offers insights into financial technology, tour and travel tips, and renewable energy solutions like solar panels. The website provides a variety of content aimed at informing and engaging a broad audience with diverse interests, from economic trends to technological innovations and practical lifestyle advice. It also covers topics such as cargo services and import/export strategies.
- Aug 2015Conventional Debt$1M
- Oct 2014Conventional Debt$4M
- May 2014Conventional Debt$1M
- Jun 2012Series B$5.5M
#10
Funding Raised · Yaphank, New York · founded 1990 · 8 employees$12.7Mraised▾
Nanoparticle technology for imaging, microscopy, and biodetection solutions. They specialize in gold nanoparticle labeling technology, offering a range of precision nanoparticle products including gold conjugates, FluoroNanogold, enhancers, labeling reagents, and microCT contrast agents. Their innovative solutions cater to electron microscopy, light microscopy, immunolabeling, and more. They provide custom synthesis services, tailoring labels with reactive groups, antibodies, and fluorescence to meet specific research needs. Their products are designed for detecting, locating, and visualizing biological molecules, offering greater range and versatility compared to conventional immunogold probes. They serve researchers and scientists in the fields of biology, medicine, and nanotechnology, providing tools for advanced imaging and detection. Their offerings include recombinant protein detection tools, negative stains for electron microscopy, and various functionalized gold nanomaterials. They focus on creating better tools and innovative solutions for research and treatments.
- 2016Grant (prize money)$225K
- 2015Grant (prize money)$252.5K
- 2014Grant (prize money)$159.7K
- 2013Grant (prize money)$247.8K
#11
Funding Raised · Stony Brook, New York · founded 2014 · 7 employees$2.7Mraised▾
Manufacturer of advanced materials for chromatography. Its product portfolio comprises an all-carbon suite of products. Its products are available as bulk stationary phase media or packed in solid-phase extraction and liquid chromatography columns. It helps in reducing laboratory costs and solvent usage. Its application is in separating structurally similar compounds, biologics, or biosimilars.
- Dec 2022Grant (prize money)—
- Sep 2022Grant (prize money)$1.5M
- Nov 2019Grant (prize money)—
- Aug 2019Grant (prize money)$169K
#12
Series B · Ithaca, New York · founded 2003 · 14 employees$7.6Mraised▾
Primet Precision Materials, Inc. is an advanced materials company focused on meeting society's critical need for improved battery performance in applications ranging from consumer handheld devices to electric and hybrid-electric vehicles. The company claims that its environmentally-friendly process technology offers dramatic savings – up to 85% reductions in both capital and operating costs for electrode material production, and with lower-cost raw materials than the industry uses today. Backed by, Draper Fisher Jurvetson, Cayuga Venture Fund (CVF), Morgan Stanley, Onondaga Venture Capital Fund, Tomoe Engineering and NYSTAR.
- Jan 2013Grant (prize money)$650K
- May 2011Series B$2.5M
- Apr 2010Series B$4.1M
- Oct 2008Conventional Debt$1.2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Nanotechnology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Nanomaterials is moving in the United States
A read on the academic research around Nanomaterials — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 7,242 United States-affiliated papers.
- Massachusetts Institute of Technology149
- Purdue University West Lafayette140
- Argonne National Laboratory125
- Stanford University124
- Lawrence Berkeley National Laboratory114
- Nanoparticle166→713
- Quantum dot32→282
- Catalysis58→282
- Quantum3→158
- Nanocomposite38→186
- Nanoparticle166→683
- Nanocomposite24→211
- Quantum dot30→162
- Catalysis46→170
- Photocatalysis17→137
- Quantum dot11→28
- Catalysis4→17
- Nanoparticle57→68
- Perovskite (structure)1→11
- Polymer5→14
Where nanomaterials is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing nanomaterials patents in the United States
United States nanomaterials patent filing is cooling — 47,771 filings from 8,000 assignees (2016–2025), led by IBM, Intel, UNIV California; annual filings 4825→4147.
- IBM5896
- Intel3517
- UNIV California3266
- Massachusetts INST Technology2026
- 3M Innovative Properties2006
- Hewlett Packard Development1430
- UNIV Texas1095
- Molecular Imprints1053
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.